+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • August 2024
  • Region: Global
  • Grand View Research
  • ID: 5998899

Smoking Cessation And Nicotine De-addiction Market Growth & Trends

The global smoking cessation and nicotine de-addiction market size is expected to reach USD 50.90 billion by 2030, growing at a CAGR of 10.4% from 2024 to 2030. The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Smoking Cessation And Nicotine De-addiction Market Report Highlights

  • Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2023. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.
  • The e-cigarette segment is anticipated to grow at a CAGR of 8.48% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.
  • North America dominated the smoking cessation and nicotine de-addiction market with a market share of 40.3% in 2023.
  • Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period.
  • The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Smoking Cessation and Nicotine De-addiction Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Smoking Cessation and Nicotine De-addiction Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2. PESTEL Analysis
3.4.3 Political landscape
3.4.4 Economic and Social landscape
3.4.5 Technological landscape
3.4.6 Environmental landscape
3.4.7 Legal landscape
Chapter 4. Smoking Cessation and Nicotine De-addiction Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Nicotine Replacement Therapy
4.2.1. Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.2 Nicotine Lozenges
4.2.2.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.3 Nicotine Gums
4.2.3.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.4 Nicotine Sprays
4.2.4.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5 Nicotine Inhalers
4.3. Drug Therapy
4.3.1. Drug Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. E-cigarettes
4.4.1. E-cigarettes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Smoking Cessation and Nicotine De-addiction Market: Form Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Smoking Cessation and Nicotine De-addiction Market: Form Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Gum
5.3.1. Gum Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Inhalers
5.4.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Tablets
5.5.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospital Pharmacies
6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Online
6.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Drug stores and Retail Pharmacies
6.5.1. Drug stores and Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Smoking Cessation and Nicotine De-addiction Market : Regional Estimates & Trend Analysis
7.1. Smoking Cessation and Nicotine De-addiction Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1 U.S. Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1 Canada Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1 Mexico Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1 UK Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1 Germany Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1 France Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1 Italy Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1 Spain Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1 Denmark Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1 Sweden Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1 Norway Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1 Japan Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1 China Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1 India Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1 Australia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1 South Korea Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1 Thailand Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1 Brazil Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1 Argentina Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1 South Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1 Saudi Arabia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1 UAE Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1 Kuwait Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Rusan Pharma Ltd
8.4.1.1 Participant’s Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Recent Developments/ Strategic Initiatives
8.4.2. Dr. Reddy’s Laboratories Ltd
8.4.2.1 Participant’s Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Recent Developments/ Strategic Initiatives
8.4.3. Imperial Brands Plc
8.4.3.1 Participant’s Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Recent Developments/ Strategic Initiatives
8.4.4. Zydus Group.
8.4.4.1 Participant’s Overview
8.4.4.2 Financial Performance
8.4.4.3 Product Benchmarking
8.4.4.4 Recent Developments/ Strategic Initiatives
8.4.5. British American Tobacco Plc
8.4.5.1 Participant’s Overview
8.4.5.2 Financial Performance
8.4.5.3 Product Benchmarking
8.4.5.4 Recent Developments/ Strategic Initiatives
8.4.6. Perrigo Company Plc
8.4.6.1 Participant’s Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Recent Developments/ Strategic Initiatives
8.4.7. Johnson and Johnson Inc
8.4.7.1 Participant’s Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Recent Developments/ Strategic Initiatives
8.4.8. NJOY, LLC
8.4.8.1 Participant’s Overview
8.4.8.2 Financial Performance
8.4.8.3 Product Benchmarking
8.4.8.4 Recent Developments/ Strategic Initiatives
8.4.9. Cipla Ltd
8.4.9.1 Participant’s Overview
8.4.9.2 Financial Performance
8.4.9.3 Product Benchmarking
8.4.9.4 Recent Developments/ Strategic Initiatives
8.4.10. GlaxoSmithKline Plc.
8.4.10.1 Participant’s Overview
8.4.10.2 Financial Performance
8.4.10.3 Product Benchmarking
8.4.10.4 Recent Developments/ Strategic Initiatives

Companies Mentioned

  • Rusan Pharma Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Imperial Brands Plc
  • Zydus Group.
  • British American Tobacco Plc
  • Perrigo Company Plc
  • Johnson and Johnson Inc
  • NJOY, LLC
  • Cipla Ltd
  • GlaxoSmithKline Plc.

Methodology

Loading
LOADING...

Table Information